Your browser doesn't support javascript.
loading
Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
Ashraf-Uz-Zaman, Md; Ji, Guangchen; Tidwell, Dalton; Yin, Linda; Thakolwiboon, Smathorn; Pan, Jie; Junell, Riley; Griffin, Zach; Shahi, Sadisna; Barthels, Derek; Sajib, Md Sanaullah; Trippier, Paul C; Mikelis, Constantinos M; Das, Hiranmoy; Avila, Mirla; Neugebauer, Volker; German, Nadezhda A.
Afiliação
  • Ashraf-Uz-Zaman M; Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States.
  • Ji G; Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
  • Tidwell D; Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
  • Yin L; Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
  • Thakolwiboon S; Garrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
  • Pan J; Neurology Department, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
  • Junell R; Neurology Department, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
  • Griffin Z; Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
  • Shahi S; Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States.
  • Barthels D; Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States.
  • Sajib MS; Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States.
  • Trippier PC; Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States.
  • Mikelis CM; Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Das H; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Avila M; UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Neugebauer V; Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States.
  • German NA; Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States.
ACS Chem Neurosci ; 13(2): 217-228, 2022 01 19.
Article em En | MEDLINE | ID: mdl-34978174

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalomielite Autoimune Experimental / Esclerose Múltipla Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalomielite Autoimune Experimental / Esclerose Múltipla Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article